Kanwal F, Kramer JR, Li L, et al
Eng approached Raufman after his talk and suggested they team up to search Gila monster venom for additional peptides with structures similar to the exendin-1 and exendin-2 molecules that Raufman first discovered
MOUNJARO and ZEPBOUND are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Review proper injection technique to ensure correct administration
Can insulin resistance or GLP-1 medications affect breast milk supply
Gastrointestinal Symptoms : nausea, vomiting, diarrhea, constipation, abdominal pain, reflux, heartburn, and impaired motility Secretomotor Symptoms : difficulty sweating, tearing, and other fluid production (dry eyes, dry mouth, difficulty swallowing, dry skin)